Navigation Links
Oclaro Announces Second Quarter Fiscal Year 2013 Financial Results
Date:1/31/2013

facility under the Credit Agreement from $50 million to $80 million.

Third Quarter Fiscal Year 2013 OutlookThe results of Oclaro for the third quarter of fiscal 2013, which ends March 30, 2013, are expected to be:

  • Revenues in the range of $140 million to $155 million.
  • Non-GAAP gross margin in the range of 10% to 14%.
  • Adjusted EBITDA in the range of negative $25 million to negative $13.5 million.
  • The foregoing guidance is based on current expectations. These statements are forward looking, and actual results may differ materially. Please see the Safe Harbor Statement in this earnings release for a description of certain important risk factors that could cause actual results to differ, and refer to Oclaro's most recent annual and quarterly reports on file with the Securities and Exchange Commission (SEC) for a more complete description of these risks. Furthermore, our outlook excludes items that may be required by GAAP, including, but not limited to, restructuring and related costs, acquisition or disposal related costs, any additional flood-related expenses, expenses or income from certain legal actions, settlements and related costs outside our normal course of business, impairments of other long-lived assets, depreciation and amortization, extraordinary items, as well as the expensing of stock options and restricted stock grants. We do not intend to update this guidance as a result of developments occurring after the date of this release.

    Conference CallOclaro will hold a conference call to discuss financial results for the second quarter of fiscal 2013 today at 1:30 p.m. PT/4:30 p.m. ET. To listen to the live conference call, please dial (480) 629-9665. A replay of the conference call will be available through February 7, 2013. To access the replay, dial (858) 384-5517. The passcode for the replay is 4593179. A webcast of this call and a supplemental presentation will be available in the investor sec
    '/>"/>

    SOURCE Oclaro, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12

    Related medicine technology :

    1. Oclaro Announces Fourth Quarter and Fiscal Year 2012 Financial Results
    2. KaloBios Pharmaceuticals Announces Pricing of Initial Public Offering
    3. CryoLife Announces Release Date and Teleconference Call Details for 2012 Fourth Quarter and Year End Financial Results
    4. Blue Belt Technologies Announces First U.S. Sale of NavioPFS Surgical System
    5. IDEV Announces Results from Revascularization with Supera on Real World Patients (RESTORE) Study, Demonstrating Positive Clinical Outcomes in Significantly Diseased Patients with Long Lesions
    6. Vanda Announces Phase IIb/III Clinical Study In Major Depressive Disorder Did Not Meet The Primary Endpoint
    7. Targovax AS Announces First Patient Included in Phase I/II Clinical Study With the Therapeutic Cancer Vaccine TG01 in Operable Pancreatic Cancer
    8. Kemwell Announces Successful Pre-NDA US FDA Inspection
    9. Cell Therapeutics Announces Data Safety and Monitoring Board Recommendation to Continue the GOG-0212 Phase 3 Clinical Trial of OPAXIOTM as Maintenance Therapy in Ovarian Cancer
    10. Keryx Biopharmaceuticals Announces Pricing of Public Offering of Common Stock
    11. Vanish Announces Tattoo Removal Giveaway for Valentines Day
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/2/2015)... Sept. 2, 2015   Physicians Rx Pharmacy ... has joined the organization as President and Chief Executive ... as President and Chief Executive Officer for Soleo Health ... Officer of Physicians Rx Pharmacy, be responsible for leading ... are extremely pleased to bring Gaston on as the ...
    (Date:9/2/2015)... Coast Tattoo Removal is the first and only laser clinic ... Southern Mississippi . Gulf Coast Tattoo Removal helps ... control of their skin. The clinic is located in ... Biloxi , Gulfport , and the entire ... as it is, I was surprised by the lack of laser ...
    (Date:9/2/2015)... Sept. 2, 2015  Neurocrine Biosciences, Inc. (Nasdaq: ... Chief Financial Officer of Neurocrine Biosciences, will be presenting ... New York City . The live ... ET (8:25am PT).  The presentation will be webcast and ... http://www.neurocrine.com .   Listeners are encouraged to ...
    Breaking Medicine Technology:Gaston L. Bernstein Named President and CEO of Physicians Rx Pharmacy 2Gulf Coast Tattoo Removal Delivers Unrivaled Tattoo Removal Results To Biloxi And Gulfport With Astanza Duality 2
    (Date:9/3/2015)... , ... September 03, 2015 , ... ... concierges; simplifying responsibilities which can impact the delicate life balance between work and ... might be.” - Jeffrey R. Leaptrott, CEO , A LifeMinder Plus® Emergency Care ...
    (Date:9/3/2015)... , ... September 03, 2015 , ... Mum n Me ... The all-new product offers an extra-large size that gives maximum protection from sun exposure, ... easy-to-use button attachment straps that deliver non-slip assurance by keeping the cover securely in ...
    (Date:9/3/2015)... ... ... looking at the types of people who have a hard time gaining weight , ... weak appetite or those that have a fast metabolism. In order to help those people ... three tips for slowing down metabolism. , The first thing to do is to space ...
    (Date:9/3/2015)... , ... September 03, 2015 , ... ... that Bob Anders and Kelley Chapman will be joining the company’s executive leadership ... , Anders has over 30 years’ experience in healthcare product and project management. ...
    (Date:9/2/2015)... (PRWEB) , ... September 03, 2015 , ... The ... wellness services - two retreats geared towards kick-starting and inspiring wellness in the Roaring ... being a part of developing a whole mind-body approach to fitness - we are ...
    Breaking Medicine News(10 mins):Health News:LifeMinder Plus® Announces Emergency Care Document Set Giveaway for America 2Health News:LifeMinder Plus® Announces Emergency Care Document Set Giveaway for America 3Health News:Mum n Me Announces New Baby Car Seat Cover 2Health News:CB-1 Weight Gainer Gives Three Tips for Slowing Down Metabolism 2Health News:CB-1 Weight Gainer Gives Three Tips for Slowing Down Metabolism 3Health News:Leading Post-Acute EMR Provider HealthWyse Names Bob Anders as VP Product and Kelley Chapman VP Engineering 2Health News:Leading Post-Acute EMR Provider HealthWyse Names Bob Anders as VP Product and Kelley Chapman VP Engineering 3Health News:TAC Introduces New Retreats for Fall Fitness 2
    ... carcinoma of the rectum. Christian Schmidt et al. describe the ... Deutsches rzteblatt International ( Dtsch Arztebl Int ... 70,000 people develop colorectal carcinoma. The aim of the study ... of life and sexual function. Data from 368 patients were ...
    ... Orleans , ... ... NEW ... , ...
    ... BEIJING , March ... ), ("Yongye or "the Company") a leading developer, manufacturer,and ... in the,People,s Republic of China (PRC), today ... Biotechnology, signed a preliminary agreement with a,local supplier of ...
    ... patients had better joint function, study found , FRIDAY, March ... replacement are usually advised to avoid high-impact sports to preserve ... participation is not only safe -- it may even help ... sports were terrible for the prosthesis," said Dr. Sebastien Parratte, ...
    ... ... betting was the third most frequently cited primary problem experienced by callers, further substantiating ... Kentucky Derby have a substantial effect on sports bettors in the state of Florida ... ...
    ... , ... The new Twinlab® Resveratrol Max DOTS™ provides healthy antioxidants found in red wine ... ... introduced the latest addition to their popular DOTS™ product line today at Natural ...
    Cached Medicine News:Health News:2010 AAOS Annual Meeting Hot Topics 2Health News:2010 AAOS Annual Meeting Hot Topics 3Health News:2010 AAOS Annual Meeting Hot Topics 4Health News:2010 AAOS Annual Meeting Hot Topics 5Health News:2010 AAOS Annual Meeting Hot Topics 6Health News:2010 AAOS Annual Meeting Hot Topics 7Health News:2010 AAOS Annual Meeting Hot Topics 8Health News:2010 AAOS Annual Meeting Hot Topics 9Health News:2010 AAOS Annual Meeting Hot Topics 10Health News:2010 AAOS Annual Meeting Hot Topics 11Health News:2010 AAOS Annual Meeting Hot Topics 12Health News:2010 AAOS Annual Meeting Hot Topics 13Health News:2010 AAOS Annual Meeting Hot Topics 14Health News:2010 AAOS Annual Meeting Hot Topics 15Health News:2010 AAOS Annual Meeting Hot Topics 16Health News:2010 AAOS Annual Meeting Hot Topics 17Health News:Yongye Nongfeng Signs Agreement to Secure Coal Resources Project in Inner Mongolia, PRC 2Health News:Yongye Nongfeng Signs Agreement to Secure Coal Resources Project in Inner Mongolia, PRC 3Health News:Yongye Nongfeng Signs Agreement to Secure Coal Resources Project in Inner Mongolia, PRC 4Health News:Yongye Nongfeng Signs Agreement to Secure Coal Resources Project in Inner Mongolia, PRC 5Health News:Yongye Nongfeng Signs Agreement to Secure Coal Resources Project in Inner Mongolia, PRC 6Health News:High-Impact Sports Might Not Harm Knee Replacements 2Health News:High-Impact Sports Might Not Harm Knee Replacements 3Health News:It's March Madness and the Florida Council on Compulsive Gambling Reminds Fans they don't have to Wager to Enjoy the Game 2Health News:Twinlab Launches New Resveratrol Supplement for Adults 2
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    Medicine Products: